Temporal dissociation of the feedback effects of dendritically co-released peptides on rhythmogenesis in vasopressin cells

Neuroscience

Volumn 124, Issue 1, 2004, Pages 105-111

  Brown, C H ^a   Ludwig, M ^a   Leng, G ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Activity patterning; Dynorphin; Supraoptic nucleus; opioid

Indexed keywords

1 [1 [4 (3 ACETAMIDOPROPOXY)BENZOYL] 4 PIPERIDYL] 1,2,3,4 TETRAHYDRO 2 QUINOLINONE; BINALTORPHIMINE; DYNORPHIN; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; PEPTIDE; URETHAN; VASOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V1 RECEPTOR;

ANESTHESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; DENDRITE; DISSOCIATION; FEEDBACK SYSTEM; FEMALE; NERVE CELL STIMULATION; NERVE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROBABILITY; PROTEIN TRANSPORT; RAT; RHYTHM; SPIKE; SUPRAOPTIC NUCLEUS; TIME;

EID: 0442323586     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2003.11.038     Document Type: Article

References (29)

1. Andrew R.D., Dudek F.E. Burst discharge in mammalian neuroendocrine cells involves an intrinsic regenerative mechanism. Science. 221:1983;1050-1052.
2. Bicknell R.J. Optimizing release from peptide hormone secretory nerve terminals. J Exp Biol. 139:1988;51-65.
3. Bicknell R.J., Brown D., Chapman C., Hancock P.D., Leng G. Reversible fatigue of stimulus-secretion coupling in the rat neurohypophysis. J Physiol. 348:1984;601-613.
4. Brown C.H., Ghamari-Langroudi M., Leng G., Bourque C.W. Kappa-opioid receptor activation inhibits post-spike depolarizing after-potentials in rat supraoptic nucleus neurones in vitro. J Neuroendocrinol. 11:1999;825-828.
5. Brown C.H., Leng G. In vivo modulation of post-spike excitability in vasopressin cells by kappa-opioid receptor activation. J Neuroendocrinol. 12:2000;711-714.
6. Brown C.H., Ludwig M., Leng G. Kappa-opioid regulation of neuronal activity in the rat supraoptic nucleus in vivo. J Neurosci. 18:1998;9480-9488.
7. Brown C.H., Russell J.A., Leng G. Opioid modulation of magnocellular neurosecretory cell activity. Neurosci Res. 36:2000;97-120.
8. Burbach J.P., De Bree F.M., Terwel D., Tan A., Maskova H.P., Van Der Kleij A.A. Properties of aminopeptidase activity involved in the conversion of vasopressin by rat brain membranes. Peptides. 14:1993;807-813.
9. Gouzenes L., Desarmenien M.G., Hussy N., Richard P., Moos F.C. Vasopressin regularizes the phasic firing pattern of rat hypothalamic magnocellular vasopressin neurons. J Neurosci. 18:1998;1879-1885.
10. Hiranuma T., Kitamura K., Taniguchi T., Kanai M., Arai Y., Iwao K., Oka T. Protection against dynorphin-(1-8) hydrolysis in membrane preparations by the combination of amastatin, captopril and phosphoramidon. J Pharmacol Exp Ther. 286:1998;863-869.
11. Hurbin A., Orcel H., Alonso G., Moos F., Rabie A. The vasopressin receptors colocalize with vasopressin in the magnocellular neurons of the rat supraoptic nucleus and are modulated by water balance. Endocrinology. 143:2002;456-466.
12. Inenaga K., Nagatomo T., Nakao K., Yanaihara N., Yamashita H. Kappa-selective agonists decrease postsynaptic potentials and calcium components of action potentials in the supraoptic nucleus of rat hypothalamus in vitro. Neuroscience. 58:1994;331-340.
13. Kombian S.B., Mouginot D., Hirasawa M., Pittman Q.J. Vasopressin preferentially depresses excitatory over inhibitory synaptic transmission in the rat supraoptic nucleus in vitro. J Neuroendocrinol. 12:2000;361-367.
14. Leng G., Brown C.H., Russell J.A. Physiological pathways regulating the activity of magnocellular neurosecretory cells. Prog Neurobiol. 57:1999;625-655.
15. Leng G, Brown D, Murphy NP (1995) Patterning of electrical activity in magnocellular neurones. In: Neurohypophysis: recent progress of vasopressin and oxytocin research (Saito T, Kurokawa K, Yoshida S, eds), pp 225-235. Amsterdam: Elsevier Science B.V.
16. + conductances generate depolarizing after-potentials in rat supraoptic nucleus neurones. J Physiol. 505:1997;95-106.
17. Lincoln D.W., Wakerley J.B. Electrophysiological evidence for the activation of supraoptic neurones during the release of oxytocin. J Physiol. 242:1974;533-554.
18. Ludwig M. Dendritic release of vasopressin and oxytocin. J Neuroendocrinol. 10:1998;881-895.
19. Ludwig M., Leng G. Autoinhibition of supraoptic nucleus vasopressin neurons in vivo A combined retrodialysis/electrophysiological study in rats . Eur J Neurosci. 9:1997;2532-2540.
20. Mason W.T., Cobbett P., Inenaga K., Legendre P. Ionic currents in cultured supraoptic neurons Actions of peptides and transmitters . Brain Res Bull. 20:1988;757-764.
21. Moos F., Gouzenes L., Brown D., Dayanithi G., Sabatier N., Boissin L., Rabie A., Richard P. New aspects of firing pattern autocontrol in oxytocin and vasopressin neurones. Adv Exp Med Biol. 449:1998;153-162.
22. Pow D.V., Morris J.F. Dendrites of hypothalamic magnocellular neurons release neurohypophysial peptides by exocytosis. Neuroscience. 32:1989;435-439.
23. Richard P., Moos F., Dayanithi G., Gouzenes L., Sabatier N. Rhythmic activities of hypothalamic magnocellular neurons Autocontrol mechanisms . Biol Cell. 89:1997;555-560.
24. 2+ influx in magnocellular vasopressin neurones isolated from the rat supraoptic nucleus. J Physiol. 503:1997;253-268.
25. Sabatier N., Richard P., Dayanithi G. Activation of multiple intracellular transduction signals by vasopressin in vasopressin-sensitive neurones of the rat supraoptic nucleus. J Physiol. 513:1998;699-710.
26. Shuster S.J., Riedl M., Li X., Vulchanova L., Elde R. The kappa opioid receptor and dynorphin co-localize in vasopressin magnocellular neurosecretory neurons in guinea-pig hypothalamus. Neuroscience. 96:2000;373-383.
27. 2+ channel currents in magnocellular neurones of the rat supraoptic nucleus. J Physiol. 513:1998;787-804.
28. Whitnall M.H., Gainer H., Cox B.M., Molineaux C.J. Dynorphin-A-(1-8) is contained within vasopressin neurosecretory vesicles in rat pituitary. Science. 222:1983;1137-1139.
29. Williams J.T., Christie M.J., Manzoni O. Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev. 81:2001;299-343.